Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes-Reference-Cited by-同舟云学术

Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes

Published:2021-11-30 Issue:8 Volume:5 Page:
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Maraveyas Anthony¹^ORCID,Beyer‐Westendorf Jan²^ORCID,Lee Agnes Y.³,Mantovani Lorenzo G.⁴⁵,De Sanctis Yoriko⁶,Abdelgawwad Khaled⁷,Fatoba Samuel⁷,Bach Miriam⁷,Cohen Alexander T⁸

Affiliation:

1. Joint Centre for Cancer Studies Hull York Medical SchoolQCOHCastle Hill Hospital Hull UK

2. Thrombosis Research Unit Department of Medicine I Division Hematology University Hospital “Carl Gustav Carus” Dresden Dresden Germany

3. Division of Hematology University of British ColumbiaBritish Columbia Cancer Agency Vancouver BC Canada

4. University of Milan Bicocca Milan Italy

5. IRCCS MultiMedica Sesto San Giovanni Italy

6. Bayer US, LLC. Whippany NJ USA

7. Bayer AG Berlin Germany

8. Department of Haematological Medicine Guys and St Thomas' NHS Foundation TrustKing's College London London UK

Funder

Bayer Portugal

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12604

Reference33 articles.

1. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer

2. Management of thrombosis in cancer: primary prevention and secondary prophylaxis

3. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer

4. Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

5. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review;Journal of Thrombosis and Thrombolysis;2024-03-01

2. Management of Cancer-Associated Thrombosis in France: A National Survey among Vascular Disease and Supportive Care Specialists;Cancers;2022-08-27

3. Unanswered questions in cancer‐associated thrombosis;British Journal of Haematology;2022-05-25